Securian Asset Management Inc. trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.1% during the 2nd quarter, Holdings Channel.com reports. The firm owned 6,334 shares of the company’s stock after selling 200 shares during the period. Securian Asset Management Inc.’s holdings in Henry Schein were worth $463,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC grew its stake in Henry Schein by 3.5% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock worth $341,000 after purchasing an additional 157 shares during the period. Equitable Trust Co. grew its stake in Henry Schein by 3.1% in the second quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock worth $388,000 after purchasing an additional 158 shares during the period. TD Asset Management Inc grew its stake in Henry Schein by 0.8% in the second quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock worth $1,608,000 after purchasing an additional 164 shares during the period. Radnor Capital Management LLC grew its stake in Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock worth $834,000 after purchasing an additional 180 shares during the period. Finally, V Square Quantitative Management LLC grew its stake in Henry Schein by 6.3% in the second quarter. V Square Quantitative Management LLC now owns 3,377 shares of the company’s stock worth $247,000 after purchasing an additional 200 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the company. UBS Group reduced their price target on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 6th. Evercore ISI raised Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price on the stock in a research note on Tuesday, August 26th. Barrington Research reissued an “outperform” rating and issued a $78.00 target price on shares of Henry Schein in a research note on Wednesday. Stifel Nicolaus reissued a “hold” rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, JPMorgan Chase & Co. cut their target price on Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a research note on Thursday, August 7th. Five research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $76.67.
Henry Schein Trading Up 0.4%
NASDAQ HSIC opened at $63.84 on Friday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market cap of $7.74 billion, a P/E ratio of 20.59, a P/E/G ratio of 2.10 and a beta of 0.81. The stock’s fifty day moving average price is $66.73 and its 200-day moving average price is $68.53. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- How to Use Stock Screeners to Find Stocks
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to Use the MarketBeat Dividend Calculator
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- Differences Between Momentum Investing and Long Term Investing
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
